Theres a reason for that
Basic Science, Current Diagnosis and Management
If you have been researching BPC-157, CJC-1295, peptide therapy, GLP-1 medications, body composition, recovery, or wellness medicine , you probably have questions
The aims of a subacromial bursal injection are to reduce the bursal inflammation achieving pain relief and allowing the rehabilitation to progress
Key gaps include: No large-scale randomised controlled trials in humans the evidence basis for clinical use is extrapolated from animal data and small pilot studies No long-term safety data effects beyond 1216 weeks are not well characterised Variable results in human sleep trials some early human studies showed modest or inconsistent effects on sleep architecture compared to animal data, suggesting the translation may not be linear No FDA approval DSIP is not approved for any therapeutic use in the United States Stability concerns DSIP degrades relatively quickly in circulation
TrustScore Make supplements work for you Get the app to see TrustScore details Nutrients Fucoxanthin 2.5mg L-Carnitine L-Tartrate 1500mg Pantothenic Acid 3mg Vitamin B6 1mg BioPerine 5mg * Manufacturer does not disclose amount